Literature DB >> 681826

Defective chemotaxis in uremia.

P Siriwatratananonta, V Sinsakul, K Stern, R G Slavin.   

Abstract

Of uremic patients, 37% demonstrated the presence of CFI in their sera. The serum factor acts directly on leukotatic factors, C5f, C3f, and BF to render them irreversibly inactive. Inhibitory activity was found in five of 16 patients: 37% to 61% for C5f, 25% to 36% for C3f, and 28% to 51% for BF. There is no correlation of this inhibitory activity with BUN or creatinine levels. The presence of this chemotactic inhibitor may be responsible for the increased incidence of infection in uremia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681826

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells.

Authors:  W H Hörl; M Haag-Weber; A Georgopoulos; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 2.  Hematologic aspects of end-stage renal failure.

Authors:  P Zachée; J Vermylen; M A Boogaerts
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

3.  Impaired polymorphonuclear leukocyte function in chronically hemodialyzed patients with iron overload.

Authors:  W Park; D H Jang; S H Kim; C S Han; W S Shin; H Y Kim; D J Kim
Journal:  Korean J Intern Med       Date:  1988-01       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.